Omega Healthcare Investors, Inc. (FRA:WX4)
Germany · Delayed Price · Currency is EUR 39.62
-0.18 (-0.45%)
Last updated: Feb 20, 2026, 6:38 PM CET
FRA:WX4 Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Rental Revenue | 1,002 | 887.91 | 826.39 | 751.23 | 923.68 |
Other Revenue | 13.02 | 6.27 | 3.46 | 3.09 | 1.72 |
Total Revenue | 1,190 | 1,051 | 949.74 | 878.24 | 1,063 |
Revenue Growth (YoY | 13.19% | 10.70% | 8.14% | -17.37% | 19.10% |
Property Expenses | 14.44 | 14.56 | 15.03 | 15.5 | 12.26 |
Selling, General & Administrative | 104.14 | 88 | 81.5 | 69.4 | 64.63 |
Depreciation & Amortization | 325.25 | 304.65 | 319.68 | 332.41 | 342.01 |
Provision for Loan Losses | -2.34 | 15.48 | -44.56 | -68.66 | -77.02 |
Total Operating Expenses | 446.16 | 391.73 | 460.77 | 485.97 | 495.92 |
Operating Income | 743.94 | 659.66 | 488.97 | 392.28 | 566.89 |
Interest Expense | -215.04 | -221.72 | -235.53 | -233.24 | -234.6 |
Income (Loss) on Equity Investments | -0.22 | 7.92 | -0.58 | 7.26 | 16.06 |
Other Non-Operating Income | 50.06 | 6.83 | 20.3 | -2 | -0.58 |
EBT Excluding Unusual Items | 578.75 | 452.69 | 273.16 | 164.3 | 347.77 |
Merger & Restructuring Charges | -4.22 | -11.62 | -5.34 | -42.01 | -1.81 |
Gain (Loss) on Sale of Assets | 67.3 | 13.17 | 79.67 | 359.95 | 161.61 |
Asset Writedown | -22.61 | -23.83 | -91.94 | -38.45 | -44.66 |
Other Unusual Items | 5 | -1.75 | -0.49 | -0.39 | -30.76 |
Pretax Income | 624.22 | 428.66 | 255.05 | 443.4 | 432.14 |
Income Tax Expense | 14.75 | 10.86 | 6.26 | 4.56 | 3.84 |
Earnings From Continuing Operations | 609.47 | 417.8 | 248.8 | 438.84 | 428.3 |
Minority Interest in Earnings | -19.28 | -11.48 | -6.62 | -11.91 | -11.56 |
Net Income | 590.19 | 406.33 | 242.18 | 426.93 | 416.74 |
Preferred Dividends & Other Adjustments | 18.16 | - | - | - | - |
Net Income to Common | 572.03 | 406.33 | 242.18 | 426.93 | 416.74 |
Net Income Growth | 45.25% | 67.78% | -43.27% | 2.44% | 161.56% |
Basic Shares Outstanding | 292 | 258 | 240 | 236 | 237 |
Diluted Shares Outstanding | 305 | 270 | 250 | 244 | 244 |
Shares Change (YoY) | 12.76% | 7.99% | 2.52% | -0.02% | 3.93% |
EPS (Basic) | 1.96 | 1.57 | 1.01 | 1.81 | 1.76 |
EPS (Diluted) | 1.94 | 1.55 | 1.00 | 1.80 | 1.75 |
EPS Growth | 25.36% | 55.44% | -44.60% | 2.48% | 151.99% |
Dividend Per Share | 2.680 | 2.680 | 2.680 | 2.680 | 2.680 |
Operating Margin | 62.51% | 62.74% | 51.48% | 44.67% | 53.34% |
Profit Margin | 48.07% | 38.65% | 25.50% | 48.61% | 39.21% |
EBITDA | 1,069 | 964.31 | 808.66 | 719.02 | 899.39 |
EBITDA Margin | 89.84% | 91.72% | 85.15% | 81.87% | 84.62% |
D&A For Ebitda | 325.25 | 304.65 | 319.68 | 326.75 | 332.5 |
EBIT | 743.94 | 659.66 | 488.97 | 392.28 | 566.89 |
EBIT Margin | 62.51% | 62.74% | 51.48% | 44.67% | 53.34% |
Funds From Operations (FFO) | 898.91 | 733.91 | 591.18 | 460.54 | 655.24 |
FFO Per Share | 2.95 | 2.71 | - | - | - |
Adjusted Funds From Operations (AFFO) | 946.16 | 778.14 | 591.18 | 460.54 | 655.24 |
AFFO Per Share | 3.10 | 2.87 | - | - | - |
FFO Payout Ratio | 86.81% | 93.40% | 108.91% | 137.43% | 97.31% |
Effective Tax Rate | 2.36% | 2.53% | 2.45% | 1.03% | 0.89% |
Revenue as Reported | 1,190 | 1,051 | 949.74 | 878.24 | 1,063 |
Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.